SLDE:NASDAQSlide Insurance Holdings, Inc. Analysis
Data as of 2026-08-02 - not real-time
$19.97
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Slide Insurance Holdings posted a striking surge in net income and premium growth, with earnings per share nearly doubling year‑over‑year and the combined ratio dropping to a strong sub‑sixty level. The company also launched a quarterly dividend, signaling confidence in cash generation, and secured a record‑breaking reinsurance program that caps its exposure in catastrophe‑prone markets. Technically, the short‑term moving average sits above the medium‑term average, supporting a bullish bias, while the relative strength index hovers around the midpoint, suggesting limited momentum pressure. However, the MACD histogram is negative and the price is testing a resistance near the recent high, implying short‑term caution. Volatility has been elevated, yet beta remains exceptionally low, indicating that broader market swings have limited impact on the stock.
From a valuation perspective, the price‑to‑earnings multiple is well beneath the industry average, and the price‑to‑book ratio suggests the market is pricing the stock conservatively relative to its book value. The upside potential implied by the technical support and resistance levels, combined with solid profitability and a modest dividend, makes the stock attractive for investors seeking a blend of growth and value attributes.
From a valuation perspective, the price‑to‑earnings multiple is well beneath the industry average, and the price‑to‑book ratio suggests the market is pricing the stock conservatively relative to its book value. The upside potential implied by the technical support and resistance levels, combined with solid profitability and a modest dividend, makes the stock attractive for investors seeking a blend of growth and value attributes.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- MACD bearish crossover
- price approaching resistance
- stable trading volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- undervalued valuation metrics
- strong earnings and margin expansion
- new dividend and robust cash position
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- low beta indicating defensive profile
- sustainable dividend backed by cash flow
- record reinsurance program reducing catastrophe risk
Key Metrics & Analysis
Financial Health
Revenue Growth47.90%
Profit Margin40.02%
P/E Ratio4.8
ROE53.88%
ROA14.36%
Debt/Equity3.23
P/B Ratio2.2
Industry P/E18.0
Technical Analysis
TrendBullish
RSI49.1
Support$19.21
Resistance$23.00
MA 20$20.67
MA 50$18.96
MA 200$17.86
MACDBearish
VolumeStable
Fear & Greed Index92.88
Valuation
Target Price$25.00
Upside/Downside25.19%
GradeUndervalued
TypeBlend
Dividend Yield1.40%
Risk Assessment
Beta0.21
Volatility53.86%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
ZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKWTS
Watts Water Technologies, Inc.
STOCKAMZN
Amazon.com, Inc.
STOCKBLK
BlackRock, Inc.
STOCKUSFD
US Foods Holding Corp.
STOCKUSAC
USA Compression Partners, LP
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.